Shinpoong Pharmaceutical Co., Ltd.
KSC: 019170.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jei-Man Ryu
- Employees
- 815
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩567.1B
- Website
- https://shinpoong.co.kr
Loading 019170…
Loading profile data…Frequently asked questions about 019170
What does Shinpoong Pharmaceutical Co., Ltd. (019170.KS) do?
Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periart...
Where does 019170.KS trade?
Shinpoong Pharmaceutical Co., Ltd. (019170.KS) trades on the Korea Exchange.
What sector is 019170.KS in?
Shinpoong Pharmaceutical Co., Ltd. (019170.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shinpoong Pharmaceutical Co., Ltd.?
Jei-Man Ryu is the chief executive officer of Shinpoong Pharmaceutical Co., Ltd. (019170.KS).
Where is Shinpoong Pharmaceutical Co., Ltd. headquartered?
Shinpoong Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 019170.KS pay a dividend?
Shinpoong Pharmaceutical Co., Ltd. (019170.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 019170.KS go public?
Shinpoong Pharmaceutical Co., Ltd. (019170.KS) completed its initial public offering in 2000.